Evidence map›Paper›PMID 30944299›Full record

ArticleCell death & disease2019

Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model.

Jianhua Wan, Xiaoyu Yang, Yuping Ren, Xueyang Li, Yin Zhu, Ashley N Haddock, Baoan Ji, Liang Xia, Nonghua Lu

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. A Robust NSCLC Biomarker- miR-7-5p: ItsMicroRNA (Shariqah, United Arab Emirates) · 2025
    Article
  12. Non-Mutational Changes of Autophagy Marker LC3A in Patients with Acute Myeloid Leukemia; Effect of DNA Methylation and Expression Level of LncRNA-GAS5 and miRNA-155-5p, A Case Control Study.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  13. Article
  14. Article
  15. Autophagy and the pancreas: Healthy and disease states.Frontiers in cell and developmental biology · 2024
    Review
  16. Review
  17. The Role of MicroRNAs in Pancreatitis Development and Progression.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jianhua WanDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
Xiaoyu YangDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
Yuping RenDepartment of Rheumatology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
Xueyang LiDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
Yin ZhuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
Ashley N HaddockDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Baoan JiDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
Liang XiaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China. xialiang79@163.com.ORCID http://orcid.org/0000-0001-7209-9407
Nonghua LuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, P. R. China. lunonghua@ncu.ecu.cn.
Nanchang University · CNMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute pancreatitis (AP) is a common digestive disease characterized by inflammation of the pancreas. MiR-155 plays a role in promoting inflammation and inhibiting the activation of anti-inflammatory pathways. Impaired autophagy could promote zymogen activation, abnormal acinar cell secretion, cell death, and the inflammatory response to aggravate AP. The aim of this study was to ascertain the effect of silencing miR-155 on AP through its effects on inflammation and impaired autophagy in vivo. In this study, AAV(adeno-associated virus)-mediated miR-155 and miR-155 sponge were injected through the tail vein of mice. After 3 weeks, AP was induced by intraperitoneal (IP) injections of cerulein. Pancreatic and pulmonary tissues were analyzed after 24 h. Silencing of miR-155 ameliorated pancreas and lung damage in three AP models of mice by preventing accumulation of autophagosomes that are unable to fuse with lysosomes and decreasing pancreatic inflammation by targeting TAB2. 3-MA could reduce the aberrant accumulation of autophagosomes, which alleviates the pancreas damage that was aggravated by increasing miR-155 levels. These findings demonstrate that the inhibition of miR-155 holds promise for limiting pancreatitis.

Indexed as

Adaptor Proteins, Signal TransducingAdenineAnimalsAutophagosomesAutophagyCeruletideDisease Models, AnimalInflammationLungMaleMiceMicroRNAsPancreasPancreatitisPrognosis3-methyladenineAdaptor Proteins, Signal TransducingAdenineCeruletideMicroRNAsMirn155 microRNA, mouseTab2 protein, mouse

Identifiers

PMID30944299
PMCPMC6447551
OpenAlexW2931812640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.